Cure My Disease

Don't miss your cure!

 Log in / Sign up

Video visits may help seniors bounce back from frailty after hospitalization

NCT ID NCT07712276

Disease control Sponsor: Indonesia University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 17, 2026 · Last updated Jul 23, 2026 · Updated 2 times

Summary

This study tests whether structured video consultations, covering exercise, nutrition, and home care, can help reverse frailty in people aged 60 and older after they leave the hospital. Participants receive three teleconsultation sessions over 12 weeks, plus standard follow-up visits. Researchers measure changes in frailty scores, hand grip strength, and blood markers like interleukin-6 and albumin to see if the program improves health behavior and frailty status.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
structured teleconsultation (behavioral intervention)
What this could lead to
If successful, this approach could offer a practical, home-based way to reverse frailty in older adults after a hospital stay, improving their strength and independence.
What could go wrong
This is a relatively small trial (116 participants) testing a behavioral intervention, so results may not apply broadly. Frailty is complex and may not reverse with teleconsultation alone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 116 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Aug 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 60 years or older * Approved for hospital discharge * Diagnosed with pre-frailty or frailty * Access to a mobile phone, tablet, or laptop Exclusion Criteria: * Unwilling to participate in the study * Depression, as indicated by a Geriatric Depression Scale (GDS) score ≥10, assessed at the time of discharge * Moderate to severe cognitive impairment, as indicated by a Montreal Cognitive Assessment-Indonesian version (MoCA-INA) score \<26, assessed at the time of discharge * Severe frailty, as indicated by a Clinical Frailty Scale (CFS) score \>8 * Liver cirrhosis * Chronic kidney disease stage 4 or higher * Stage 4 malignancy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Frail elderly are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Frailty

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Frail elderly Prefrail elderly

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Cipto Mangunkusumo Hospital

    Jakarta, Central Jakarta, 10430, Indonesia

More trials for these conditions

Other studies related to the condition(s) this trial covers.